2010 News

12.13.2010 Press Release

Santen Launches DIQUAS Ophthalmic Solution 3% for Dry Eye Treatment in Japan

11.02.2010 Press Release

Santen Announces Financial Result for the Second Quarter ended September 30, 2010

09.28.2010 Press Release

Reorganization of manufacturing function and transfer of Osaka plant

08.03.2010 Press Release

Santen Announces Financial Result for the First Quarter ended June 30, 2010

07.06.2010 Press Release

Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)

06.23.2010 Press Release

Notice on the Allotment of Stock Options (Stock Acquisition Rights)

06.11.2010 Press Release

Banyu and Santen Launch COSOPT® Combination Ophthalmic Solution: Glaucoma and Ocular Hypertension Drug

05.11.2010 Press Release

Santen Announces Financial Results for the Year ended March 31, 2009

05.11.2010 Press Release

Renewal of the Countermeasures to Large-Scale Purchases of the Corporation's Shares (Takeover Defense Measures)

05.11.2010 Press Release

Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Directors

05.11.2010 Press Release

Santen to Issue Rights to Subscribe for New Shares as Stock Options in favor of Corporate Officers

05.11.2010 Press Release

Notice of the Change of Representative Director and the Nominations for the Members of the Board of Directors

05.06.2010 Press Release

Santen Launches Glaucoma and Ocular Hypertension Treatment TAFLOTAN® in Korea

05.03.2010 Press Release

Clinical Data, Inc. Licenses Adenosine A2A Agonist to Santen for Development of Ophthalmic Treatments

04.16.2010 Press Release

Santen Announces Approval of DIQUAS for Dry Eye Treatment in Japan

04.16.2010 Press Release

MHLW Grants Approval for COSOPT Combination Ophthalmic Solution

03.10.2010 Press Release

Notice of the appointment of Corporate Officers

03.10.2010 Press Release

Change of management positions at Santen Inc.

03.02.2010 Press Release

Banyu and Santen Announce Co-Promotion Agreement for Combination Ophthalmic Solution, Treatment for Glaucoma and Ocular Hypertension

03.02.2010 Press Release

Santen Files Manufacturing/Marketing Approval of its Broad Spectrum Anti-Infective Ophthalmic Solution DE-108 (Generic name: Levofloxacin, high concentration)

02.02.2010 Press Release

Santen Announces Financial Result for the Third Quarter ended December 31, 2009